These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9270473)

  • 1. Drug treatment for benign prostatic hyperplasia. Health authorities must audit use of finasteride.
    Mendelsohn R; Thompson D
    BMJ; 1997 Aug; 315(7104):370-1. PubMed ID: 9270473
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: an economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    Can J Urol; 2005 Feb; 12(1):2508-9; author reply 2509-10. PubMed ID: 15777487
    [No Abstract]   [Full Text] [Related]  

  • 3. Finasteride to prevent morbidity from benign prostatic hyperplasia.
    Wasson JH
    N Engl J Med; 1998 Feb; 338(9):612-3. PubMed ID: 9475770
    [No Abstract]   [Full Text] [Related]  

  • 4. An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    McDonald H; Hux M; Brisson M; Bernard L; Nickel JC
    Can J Urol; 2004 Aug; 11(4):2327-40. PubMed ID: 15380054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. By the way, doctor. I have been taking Avodart for my BPH, along with Flomax, but finasteride may be less expensive. Should I switch?
    Richie JP
    Harv Health Lett; 2008 Jul; 33(9):8. PubMed ID: 18780418
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cost-effectiveness aspects of benign prostatic hyperplasia (BPH) therapy].
    Lopatkin NA; Ziborova IV; Sivkov AV; Apolikhin OI
    Urol Nefrol (Mosk); 1999; (1):22-6. PubMed ID: 11149340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment for benign prostatic hyperplasia. Several trials have shown benefit of finasteride.
    Collins GN
    BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270474
    [No Abstract]   [Full Text] [Related]  

  • 8. An economic evaluation of finasteride for treatment of benign prostatic hyperplasia.
    Baladi JF; Menon D; Otten N
    Pharmacoeconomics; 1996 May; 9(5):443-54. PubMed ID: 10160256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of benign prostatic hyperplasia. A pharmacoeconomic perspective.
    Eri LM; Tveter KJ
    Drugs Aging; 1997 Feb; 10(2):107-18. PubMed ID: 9061268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost comparison of finasteride and dutasteride for enlarged prostate in a managed care setting among Medicare-aged men.
    Naslund M; Eaddy MT; Kruep EJ; Hogue SL
    Am J Manag Care; 2008 May; 14(5 Suppl 2):S167-71. PubMed ID: 18611091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Combination Therapy Versus Monotherapy in Benign Prostatic Hyperplasia: A Colombian Experience.
    Guevara-Cuellar CA; Parody-Rúa E; Garcia-Perdomo HA; Arenas-Duque A
    Value Health Reg Issues; 2018 Dec; 17():174-182. PubMed ID: 30415110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benign prostatic hyperplasia. Finasteride controls progression of BPH].
    MMW Fortschr Med; 2000 Jun; 142(25):62-3. PubMed ID: 10920676
    [No Abstract]   [Full Text] [Related]  

  • 13. [Finasteride in prolonged therapy of patients with benign prostatic hyperplasia].
    Mazo EB
    Urologiia; 2001; (3):20-2. PubMed ID: 11505535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment for benign prostatic hyperplasia. To interpret PSA concentrations in patients taking finasteride, multiply them by two.
    Taneja S
    BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270475
    [No Abstract]   [Full Text] [Related]  

  • 15. Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasia.
    Wilde MI; Goa KL
    Drugs; 1999 Apr; 57(4):557-81. PubMed ID: 10235693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finasteride therapy for benign prostatic hyperplasia.
    Helling TJ
    CMAJ; 2008 Feb; 178(5):596-7. PubMed ID: 18299551
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia.
    Atan A
    J Urol; 1998 Jul; 160(1):134. PubMed ID: 9628630
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
    Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of benign prostatic hyperplasia. The Scandinavian BPH Study Group.
    Andersen JT
    Lancet; 1996 May; 347(9010):1270. PubMed ID: 8622491
    [No Abstract]   [Full Text] [Related]  

  • 20. Finasteride in benign prostatic hyperplasia.
    Verhamme KM; Bosch RJ; Sturkenboom MC
    N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.